Literature DB >> 16954337

Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution.

Filip K Knop1, Tina Vilsbøll, Steen Larsen, Patricia V Højberg, Aage Vølund, Sten Madsbad, Jens J Holst, Thure Krarup.   

Abstract

We aimed to investigate how assimilation of nutrients affects the postprandial responses of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) and to evaluate the effect of pancreatic enzyme substitution (PES) on insulin secretion in patients with chronic pancreatitis (CP) and pancreatic exocrine insufficiency (PEI). Eight male patients with CP and PEI were studied. Blood was sampled frequently on two separate days after ingestion of a liquid meal with and without PES, respectively. Eight healthy male subjects served as a control group. beta-Cell responsiveness was estimated as changes in insulin secretion rates in response to changes in postprandial plasma glucose (PG). There was no difference in the PG incremental area under curve (AUC) for patients with and without PES [406 +/- 100 vs. 425 +/- 80 mM.4 h (mean +/- SE), P = 0.8]. The response of total GLP-1 was higher after PES (AUC: 7.8 +/- 1.2 vs. 5.3 +/- 0.6 nM.4 h, P = 0.01), as was the response of total GIP (AUC: 32.7 +/- 7.5 vs. 21.1 +/- 8.3 nM.4 h, P = 0.01). Concurrently, both plasma insulin, plasma C-peptide, and total insulin secretion increased after PES (AUC: 17.7 +/- 4.2 vs. 13.6 +/- 2.9 nM.4 h, P = 0.02; 237 +/- 31.4 vs. 200 +/- 27.4 nM.4 h, P = 0.005; and 595 +/- 82 vs. 497 +/- 80 pmol.kg(-1).4 h, P = 0.01, respectively). beta-Cell responsiveness to glucose was not significantly different on the two study days for patients with CP. These results suggest that the secretion of GLP-1 and GIP is under influence of the digestion and absorption of nutrients in the small intestine and that PES increases insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954337     DOI: 10.1152/ajpendo.00059.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  39 in total

Review 1.  Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities.

Authors:  Melvin R Hayden; Kamlesh Patel; Javad Habibi; Deepa Gupta; Seema S Tekwani; Adam Whaley-Connell; James R Sowers
Journal:  J Cardiometab Syndr       Date:  2008

2.  Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012.

Authors:  Michael R Rickels; Melena Bellin; Frederico G S Toledo; R Paul Robertson; Dana K Andersen; Suresh T Chari; Randall Brand; Luca Frulloni; Michelle A Anderson; David C Whitcomb
Journal:  Pancreatology       Date:  2013-05-17       Impact factor: 3.996

3.  Early Alterations in Glycemic Control and Pancreatic Endocrine Function in Nondiabetic Patients With Chronic Pancreatitis.

Authors:  Rachel Lundberg; Gregory J Beilman; Ty B Dunn; Tim L Pruett; Martin L Freeman; Peggy E Ptacek; Katherine Louise Berry; R Paul Robertson; Antoinette Moran; Melena D Bellin
Journal:  Pancreas       Date:  2016-04       Impact factor: 3.327

Review 4.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Authors:  Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

Review 5.  The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis.

Authors:  S N Duggan; N Ewald; L Kelleher; O Griffin; J Gibney; K C Conlon
Journal:  Eur J Clin Nutr       Date:  2016-07-13       Impact factor: 4.016

6.  Genetics and treatment options for recurrent acute and chronic pancreatitis.

Authors:  Celeste A Shelton; David C Whitcomb
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

7.  Chronic Pancreatitis in the 21st Century - Research Challenges and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Aliye Uc; Dana K Andersen; Melena D Bellin; Jason I Bruce; Asbjørn M Drewes; John F Engelhardt; Christopher E Forsmark; Markus M Lerch; Mark E Lowe; Brent A Neuschwander-Tetri; Stephen J OʼKeefe; Tonya M Palermo; Pankaj Pasricha; Ashok K Saluja; Vikesh K Singh; Eva M Szigethy; David C Whitcomb; Dhiraj Yadav; Darwin L Conwell
Journal:  Pancreas       Date:  2016-11       Impact factor: 3.327

Review 8.  The role of fecal elastase-1 in detecting exocrine pancreatic disease.

Authors:  John S Leeds; Kofi Oppong; David S Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-05-31       Impact factor: 46.802

9.  Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.

Authors:  Dana K Andersen; Åke Andren-Sandberg; Eric J Duell; Michael Goggins; Murray Korc; Gloria M Petersen; Jill P Smith; David C Whitcomb
Journal:  Pancreas       Date:  2013-11       Impact factor: 3.327

10.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.